A three-drug regimen was shown to lengthen the amount of time before cancer progressed to the central nervous system in certain patients with breast cancer.
Dr. Alexis Leal provides insight on fibrolamellar hepatocellular carcinoma (HCC), a very rare liver cancer that tends to strike children and young adults.